AVNS AVANOS MEDICAL, INC.

NYSE avanos.com


$ 11.45 $ -0.03 (-0.26 %)    

Friday, 17-Oct-2025 15:59:40 EDT
QQQ $ 604.92 $ 3.94 (0.66 %)
DIA $ 461.73 $ 2.22 (0.48 %)
SPY $ 665.28 $ 3.75 (0.57 %)
TLT $ 91.09 $ -0.14 (-0.15 %)
GLD $ 391.28 $ -7.46 (-1.88 %)
$ 11.44
$ 11.48
$ 10.52 x 1
$ 12.00 x 10
$ 11.34 - $ 11.60
$ 9.30 - $ 23.68
381,736
na
530.84M
$ 1.04
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-05-2025 06-30-2025 10-Q
2 05-06-2025 03-31-2025 10-Q
3 02-26-2025 01-01-1970 10-K
4 10-30-2024 09-30-2024 10-Q
5 07-31-2024 06-30-2024 10-Q
6 05-02-2024 03-31-2024 10-Q
7 02-21-2024 12-31-2023 10-K
8 11-01-2023 09-30-2023 10-Q
9 08-09-2023 06-30-2023 10-Q
10 05-03-2023 03-31-2023 10-Q
11 02-21-2023 12-31-2022 10-K
12 11-02-2022 09-30-2022 10-Q
13 08-09-2022 06-30-2022 10-Q
14 05-04-2022 03-31-2022 10-Q
15 02-23-2022 12-31-2021 10-K
16 11-02-2021 09-30-2021 10-Q
17 08-03-2021 06-30-2021 10-Q
18 05-07-2021 03-31-2021 10-Q
19 02-19-2021 12-31-2020 10-K
20 11-03-2020 09-30-2020 10-Q
21 08-04-2020 06-30-2020 10-Q
22 05-06-2020 03-31-2020 10-Q
23 02-25-2020 12-31-2019 10-K
24 11-05-2019 09-30-2019 10-Q
25 08-06-2019 06-30-2019 10-Q
26 05-07-2019 03-31-2019 10-Q
27 02-26-2019 12-31-2018 10-K
28 11-06-2018 09-30-2018 10-Q
29 08-07-2018 06-30-2018 10-Q
30 05-02-2018 03-31-2018 10-Q
31 02-27-2018 12-31-2017 10-K
32 11-01-2017 09-30-2017 10-Q
33 08-02-2017 06-30-2017 10-Q
34 05-02-2017 03-31-2017 10-Q
35 02-27-2017 12-31-2016 10-K
36 11-03-2016 09-30-2016 10-Q
37 08-05-2016 06-30-2016 10-Q
38 05-09-2016 03-31-2016 10-Q
39 02-29-2016 12-31-2015 10-K
40 11-04-2015 09-30-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 kimberly-clark-to-pay-around-40-million-over-surgical-gown-designs

Kimberly-Clark will pay $40.4 million to settle a criminal charge after selling mislabeled surgical gowns.

 avanos-medical-appoints-svp-scott-galovan-as-svp-cfo-effective-aug-1-2025

Avanos Medical, Inc. (NYSE:AVNS), a leading medical technology company, today announced the appointment of Scott Galovan as its...

 avanos-medical-affirms-fy2025-adj-eps-guidance-of-075-095-vs-085-est-affirms-fy2025-sales-guidance-of-665000m-685000m-vs-672000m-est

  2025 OUTLOOK Estimated RangeDiluted earnings per share (GAAP)$                 

 avanos-medical-affirms-fy2025-gaap-eps-guidance-of-033-056-vs-088-est

2025 OUTLOOK Estimated RangeDiluted earnings per share (GAAP)$                 

 avanos-medical-q2-adj-eps-017-beats-015-estimate-sales-175000m-beat-165500m-estimate

Avanos Medical (NYSE:AVNS) reported quarterly earnings of $0.17 per share which beat the analyst consensus estimate of $0.15 by...

 avanos-medical-lowers-fy2025-gaap-eps-guidance-from-063-086-to-033-056

Avanos Medical (NYSE:AVNS) lowers FY2025 GAAP EPS guidance from $0.63-$0.86 to $0.33-$0.56..

 avanos-medical-lowers-fy2025-adj-eps-guidance-from-105-125-to-075-095-vs-112-est-affirms-fy2025-sales-guidance-of-66500m-68500m-vs-67350m-est

Avanos Medical (NYSE:AVNS) lowers FY2025 Adj EPS guidance from $1.05-$1.25 to $0.75-$0.95 vs $1.12 analyst estimate. Affirms FY...

 avanos-medical-q1-adj-eps-026-beats-018-estimate-sales-16750m-beat-16175m-estimate

Avanos Medical (NYSE:AVNS) reported quarterly earnings of $0.26 per share which beat the analyst consensus estimate of $0.18 by...

 avanos-medical-plans-to-take-direct-responsibility-for-sales-and-distribution-of-its-mic-key-enteral-feeding-products-in-uk-effective-july-25-2025

With this transition, Avanos will manage all sales, support, and distribution directly, reinforcing its dedication to deliverin...

 avanos-medical-q4-adj-043-beats-040-estimate-sales-17960m-beat-17723m-estimate

Avanos Medical (NYSE:AVNS) reported quarterly earnings of $0.43 per share which beat the analyst consensus estimate of $0.40 by...

 avanos-medical-announced-that-the-cms-has-issued-its-final-medicare-hospital-opps-and-medicare-asc-payment-system-rule-for-2025-effective-jan-1-2025-implements-the-non-opioids-prevent-addiction-in-the-nation-act-that-mandates-separate-medicare-payment-for-qualifying-non-opioid-drugs-and-devices

Avanos Medical, Inc. (NYSE:AVNS) announced today that the Centers for Medicare and Medicaid Services (CMS) has issued its final...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION